To further investigate whether SETDB1 promoted HCC progression by activating AKT, we employed ELISA to determine the expression of the AKT pathway-related factors AKT and mTOR and their phosphorylation levels. This evidence concerns the gene MTOR and hepatocellular carcinoma.